Exploration of health dimensions to be included in multi-attribute health-utility assessment by Perneger, Thomas V. & Courvoisier, Delphine S.
Exploration of health dimensions to be
included in multi-attribute health-utility
assessment
THOMAS V. PERNEGER1,2 AND DELPHINE S. COURVOISIER1,2
1Division of Clinical Epidemiology, University Hospitals of Geneva, Geneva, Switzerland, and 2Faculty of Medicine, University of Geneva,
Geneva, Switzerland
Address reprint requests to: Division of Clinical Epidemiology, University Hospitals of Geneva, 4 rue Gabrielle Perret-Gentil, CH-1211
Geneva, Switzerland. Tel: þ41-22-372-9037; Fax: þ41-22-372-9036; E-mail: Thomas.Perneger@hcuge.ch
Accepted for publication 7 October 2010
Abstract
Objective. Measurement of health utility is important for quality improvement, but instruments vary in their content. Multi-
attribute health utility measures typically assess a small number of health problems, e.g. the EuroQoL EQ-5D questionnaire
explores ﬁve dimensions of health. We aimed to examine whether a small number of dimensions explains a sufﬁcient amount
of variance in self-perceived health, and what can be gained from adding additional dimensions.
Design. Cross-sectional mail survey that explored health utility and self-perceived health.
Setting. General resident population of French-speaking Switzerland.
Participants. Non-institutionalized adults.
Main outcome measures. EQ-5D (which measures mobility, self-care, usual activities, pain/discomfort, anxiety/depression
and a visual analogue health scale between 0 and 100 (VAS)). A subsample rated ﬁve additional health dimensions (sleep,
memory/concentration, energy/fatigue, sight/hearing, contacts with others).
Results. In total, 349 adults returned the extended 10-item questionnaire. All added items were strongly and signiﬁcantly
associated with the VAS for perceived health. The proportion of variance explained (R2) in the VAS was 0.47 for the original
EQ-5D items (adjusted for attenuation: 0.65), 0.47 for the new items (adjusted for attenuation: 0.65) and 0.56 for the 10
items together (adjusted for attenuation: 0.78). Forty-four percent of the respondents who had a perfect health utility on the
EQ-5D reported at least one problem in the new health dimensions.
Conclusion. Self-perceived health among the general public is inﬂuenced by more health dimensions than are typically
measured in a multi-attribute health-utility instrument.
Keywords: health utility, outcome assessment (health care), quality indicators, health care, health surveys, models, statistical
Introduction
Patient outcomes measures are an important part of quality
improvement. Among them, health-utility measures are par-
ticularly useful because they allow comparisons of health
interventions across disease groups, and are required for
economic analyses. Health utility, the value attributed to a
given health state, can be measured directly by preference-
based methods, such as the standard gamble or the time
trade-off, or approximated by multi-attribute instruments,
such as the EQ-5D [1, 2], the Health Utilities Index (HUI)
[3, 4] and the SF-6D [5]. The latter identify the level of func-
tion or ability in several dimensions of health, and map these
health states onto a health-utility scale established by
preference-based methods.
To be usable such instruments typically probe only a
handful of health dimensions. Inevitably, unmeasured dimen-
sions of health cannot inﬂuence the utility assessment, so
that all utilities will be incorrect to some extent. This would
not be a problem if the distribution of utility losses by health
dimension obeyed the Pareto principle—i.e. if a small
number of health problems explained the majority of the
utility losses in a population. However, this assumption is
largely unproven. On the contrary, available evidence
suggests that this assumption may be wrong. Indeed, existing
multi-attribute instruments vary in the dimensions they
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measure (Table 1), and health utilities obtained with different
instruments agree only moderately [6–11].
To explore this issue further we considered the EQ-5D,
the most widely used multi-attribute health-utility instrument
(a recent standardized Medline search retrieved 1004 articles
for EQ-5D, 147 for HUI and 122 for SF-6D). However, the
question of how many dimensions are necessary is not
speciﬁc to this instrument, but concerns the multi-attribute
measurement strategy in general. EQ-5D measures ﬁve
dimensions of health—mobility, self-care, usual activities,
pain and discomfort and anxiety or depression. Substantial
proportions of the general population obtain ‘perfect’
health-utility values on the EQ-5D, yet these respondents
vary in their self-assessment of health on the EQ-5D visual
analogue scale (VAS), or as captured by other health status
indicators [12–16]. This suggests that EQ-5D may omit rel-
evant dimensions of health. Of note, an early version of the
instrument included an item for fatigue and tiredness [17],
and two previous studies tested an item for cognitive per-
formance [18, 19], but no study has explored the conse-
quences of including a broader set of health dimensions.
Assessing the contributions of additional dimensions to
health utility is potentially daunting. The EQ-5D describes
243 distinct health states, but doubling the number of items
would yield 59 049 health states. A valuation task for even a
small fraction of this many health states would be challenging.
To avoid this difﬁculty, we analysed self-perception of health
instead of health utility. While these concepts differ—health
utility depends on values and preferences associated with
health states, unlike general health perception—we assumed
that it would be unlikely that a health problem should affect
health utility but not self-perception of health, and vice versa.
In this study, we aimed to determine how much variance
in self-perceived health would be explained by the 5 original
dimensions of the EQ-5D, by 5 additional health dimensions
and by all 10 dimensions used together.
Methods
Study design
We conducted a general population mail survey in French-
speaking Switzerland [12]. To measure health utility, the
majority of the participants completed the standard EQ-5D,
including the ﬁve dimension-speciﬁc items—mobility, self-
care, usual activities, pain and discomfort, anxiety and
depression—and the ‘thermometer’ VAS that measures self-
perceived health. A randomly selected subset completed an
expanded version, in which ﬁve additional dimensions were
added—sleep, memory and concentration, energy and
fatigue, sight and hearing and contacts with others. We
selected these additional dimensions based on a review of
existing health-utility instruments [3–5] and general health
status questionnaires [20–28]. Sleep is included in the Duke
Health Proﬁle (DHP) [20], the Nottingham Health Proﬁle
(NHP) [21], the Sickness Impact Proﬁle (SIP) [22] and the
World Health Organization Quality of Life Scale
(WHOQOL) [23]. Cognitive ability is measured by the DHP,
HUI, WHOQOL and the Medical Outcome Study HIV
questionnaire (MOS-HIV) [24]. Energy and fatigue are
measured by the SF-6D, NHP, the Quality of Life Index
[25], the Short-Form 36 [26] and WHOQOL. Vision and
hearing are included in the HUI, the McMaster Health Index
Questionnaire [27] and SIP. Social contacts are assessed by
the SF-6D, the Short-Form 36, the COOP Charts for
Primary Care Practice [28], DHP, NHP, SIP and WHOQOL.
Study variables
The questionnaire began with the measure of health utility,
the EQ-5D in its original form, or expanded to 10 items.
This was followed by a question asking whether the previous
items addressed all important aspects of the respondent’s
health (answers were yes, completely, yes, in part, no), and an
open question about what dimensions of health were missing
(answers to this open question are not analysed in this
paper). Further items included current health status on a
5-point scale between poor and excellent, current treatment
for a chronic or acute health problem, doctor visit in past
6 months, hospital stay in past 6 months, sex, age, country of
birth and highest education.
Data collection
Data collection was conducted by an independent survey
ﬁrm (Infometrics, Le Muids, Switzerland) which had up to
date lists of residents of the selected cantons. This ﬁrm
selected the random sample of adult residents (20 years or
older), mailed the survey packages, collected the numbered
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Table 1 Comparison of dimensions of health assessed in
health-utility questionnaires
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returned questionnaires, sent out reminder packages (up to
two reminders to non-respondents), performed data entry
and transmitted the anonymous data ﬁle to the investigators.
The survey package included a cover letter, the questionnaire
booklet and a prepaid return envelope. The letter explained
the purpose of the study, identiﬁed study investigators (with
telephone number) and survey ﬁrm, described conﬁdentiality
procedures and stated that participation was voluntary. To
signify consent to participate, the respondent was asked to
return the completed questionnaire, and to signify refusal, to
send back the questionnaire empty, in which case no remin-
ders were sent. The study was approved by the research
ethics committee at the University Hospitals of Geneva.
Sample size estimation
The primary purpose of the survey was to obtain population
norms for EQ-5D [12], for which the target sample size was
1645. Allowing for 10% of invalid addresses and a response
rate of 45%, a simple random sample of 4000 individuals
was initially contacted. Of these, 3250 received the standard
version of EQ-5D, and 750 received the 10-item version, to
insure that at least 300 respondents would have completed
the 10-item questionnaire.
Statistical analysis
We compared the subsamples who answered the standard
EQ-5D and the extended 10-item version. We examined the
distributions of the EQ-5D items and the ﬁve additional
items, and computed mean values of the VAS across levels
of problems for each item.
To examine the independent contributions of problems in
the health dimensions to self-perceived health, we used two
types of analyses. First, we used a linear regression model
with the health VAS as the dependent variable, and obtained
the proportion of variance in health explained by health pro-
blems (adjusted R2). The health problems were treated as
linear covariates, because the limited sample size posed difﬁ-
culties in estimating the effects of severe problems for most
dimensions. We corrected the R2 results for the attenuation
caused by imperfect measurements [29], assuming reliability
coefﬁcients of 0.80 for the health VAS and 0.90 for the
linear combination of health dimensions. For simplicity, we
displayed regression coefﬁcients (i.e. differences in VAS) for
the absence versus presence of a problem, combining mod-
erate and severe problems.
Second, we used logistic regression with the rating of health
(‘excellent’ or ‘very good’ versus ‘good’, ‘fair’ or ‘poor’, which
resulted in two groups of similar size) as the dependent vari-
able, and obtained the area under the receiver operating
characteristic curve (ROC). These analyses were conducted on
the total sample (for the original 5 dimensions only), and on
the subsample who completed the extended questionnaire,
comparing the models with 5 original dimensions, 5 new
dimensions and all 10 dimensions. The analysis of variance
explained was repeated in various population subgroups.
To explore the ceiling effect of the EQ-5D, we examined
frequencies of problems on the new dimensions among
respondent who achieved maximum scores on the original
instrument. Then, we compared those who reported no pro-
blems on any of the 10 dimensions with those who reported
problems on the new dimensions only, in terms of acute or
chronic health problems, doctor visits or hospitalizations in




After exclusion of 253 invalid addresses (undeliverable mail),
3747 persons remained eligible (3047 in the original EQ-5D
group, 700 for the extended version) and 1952 returned the
questionnaire (52.1%); 1603 the standard EQ-5D question-
naire and 349 the extended version. The response rate was
higher for the standard questionnaire than for the extended
questionnaire (52.6 vs. 49.9%, P ¼ 0.19), and for women
compared with men (56.5 vs. 46.7%, P, 0.001).
Among the 349 respondents who answered the extended
questionnaire, 181 were women (51.9%), and the mean age
was 50.6 years [standard deviation (SD) 16.5]. The majority
was born in Switzerland (74.1%), had received only elemen-
tary or vocational education (60.5%), and reported a doctor
visit in the past 6 months (76.4%), but few had been hospi-
talized (8.5%). Acute and chronic health problems were
reported by 13.0 and 34.8% of respondents, respectively, and
47.6% rated their health as excellent or very good. The mean
VAS health score was 80.9 (SD 14.6).
Health problems
Among respondents who ﬁlled in all 10 health dimensions,
most reported no problems with mobility, self-care or usual
activities, but problems with pain or discomfort (48.2%) and
with anxiety or depression (34.2%) were quite common
(Table 2). Of the ﬁve new dimensions, the most frequent
source of complaints was fatigue/energy (52.5%), but pro-
blems with sleep (36.8%), memory and concentration
(35.6%) and with seeing or hearing (28.5%) were also
common. In contrast, only few (7.0%) reported problems in
contacts with others.
All 10 problems were strongly and signiﬁcantly associated
with the mean rating of health on the VAS (Table 2). Taking
as an example the most common problem in the original
EQ-5D, the mean VAS score was 84.7 in respondents who
were not anxious or depressed, 74.8 in those moderately
anxious or depressed and 53.4 in those who were extremely
anxious or depressed. For the most common problem
among the new items (tiredness and lack of energy), the gra-
dient in the mean VAS for the three response categories was
88.1, 76.4 and 53.0.
Correlations between the newly proposed dimensions and
the original dimensions of EQ-5D were weak to moderate
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(mean 0.28, SD 0.11, range 0.11–0.48). This was similar to
correlations among the original 5 dimensions (mean 0.29,
SD 0.13, range 0.11–0.54).
Prediction of global health from
dimension-specific problems
In multivariate linear regression analysis, problems in all ﬁve
EQ-5D dimensions were signiﬁcantly associated with the
VAS health rating (Table 3). The adjusted R2 of the model
was 0.46 among all respondents and 0.47 among those who
ﬁlled the extended version of the questionnaire. Among the
latter subsample, if only the ﬁve new health problems were
used as predictors, the adjusted R2 of the model was 0.47,
same as for the original EQ-5D items. The predicted health
scores obtained from the original EQ-5D dimensions and
from the new dimensions had a correlation of 0.70, i.e. a
shared variance of 0.49. Inclusion of all 10 items yielded an
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Table 2 Distributions of the ﬁve EQ-5D items and of the ﬁve additional items among 349 adult residents of
French-speaking Switzerland, and association with VAS (thermometer)
EQ-5D original dimensions n (%) Mean VAS (SD)
Mobility (three missing) (P, 0.001)
I have no problems in walking about 310 (89.6) 83.3 (12.2)
I have some problems in walking about 36 (10.4) 58.4 (16.9)
I am conﬁned to bed 0 (0) –
Self-care (four missing) (P, 0.001)
I have no problems with self-care 338 (98.0) 81.6 (13.7)
I have some problems washing or dressing myself 7 (2.0) 48.2 (19.2)
I am unable to wash or dress myself 0 (0) –
Usual activities (three missing) (P, 0.001)
I have no problems with performing my usual activities 311 (89.9) 84.5 (11.7)
I have some problems with performing my usual activities 32 (9.2) 57.9 (17.3)
I am unable to perform my usual activities 3 (0.9) 52.0 (24.0)
Pain/discomfort (ﬁve missing) (P, 0.001)
I have no pain or discomfort 178 (51.7) 87.4 (10.2)
I have moderate pain or discomfort 159 (45.6) 74.8 (14.2)
I have extreme pain or discomfort 9 (2.6) 53.4 (23.7)
Anxiety/depression (four missing) (P, 0.001)
I am not anxious or depressed 225 (65.2) 84.7 (11.0)
I am moderately anxious or depressed 114 (33.0) 75.6 (15.6)
I am extremely anxious or depressed 6 (1.2) 40.7 (18.0)
Additional dimensions
Sleep (one missing) (P, 0.001)
I have no problems with sleep 220 (63.2) 85.1 (11.9)
I have moderate difﬁculties with sleep 111 (31.9) 76.3 (13.5)
I have extreme difﬁculties with sleep 17 (4.9) 56.0 (19.9)
Memory/concentration (one missing) (P, 0.001)
I have no problems with memory or concentration 224 (64.4) 85.5 (10.8)
I have moderate difﬁculties with memory or concentration 120 (34.5) 73.8 (15.9)
I have extreme difﬁculties with memory or concentration 4 (1.1) 47.2 (18.1)
Fatigue/energy (two missing) (P, 0.001)
I feel full of pep 165 (47.6) 88.1 (9.4)
I am moderately tired or lacking in energy 164 (47.3) 76.4 (12.9)
I am extremely tired or lacking in energy 18 (5.2) 53.0 (20.4)
Seeing and hearing (with glasses, contact lenses or hearing aid
if you have them) (six missing)
(P, 0.001)
I see and hear without difﬁculty 245 (71.4) 83.3 (11.3)
I have moderate difﬁculties seeing or hearing 91 (26.5) 72.6 (16.5)
I have extreme difﬁculties seeing or hearing 7 (2.0) 64.2 (31.4)
Contacts with others (two missing) (P, 0.001)
I have very good contacts with my family and friends 323 (93.1) 82.4 (12.7)
I lack contact with my family and friends 21 (6.1) 67.0 (18.8)
I am completely isolated from my family and friends 3 (0.9) 50.0 (36.1)
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adjusted R2 of 0.56 (R2 change: 0.09, P, 0.001). In the
ﬁnal model, the effect of anxiety/depression virtually disap-
peared (regression coefﬁcient near zero) and became non-
signiﬁcant (Table 3). Correction for attenuation by imperfect
reliability increased the observed R2 coefﬁcients from 0.47 to
0.65, and from 0.56 to 0.78 (Table 4).
Assessment of the variance explained was repeated in
various population subgroups (Table 4). The original dimen-
sions explained more variance in health among women than
among men. The variance explained was lower among the
Swiss than among foreign-born respondents, and particularly
among the more educated and those who did not report any
chronic health problem.
We used the rating of health as ‘excellent’ or ‘very good’ as
opposed to ‘good’, ‘fair’ or ‘poor’ as the dependent variable in
a logistic regression model. Using problems on the 5 standard
EQ-5D dimensions as predictors, the area under the ROC
curve was 0.79 (P, 0.001), both in the full sample and in
the subset who responded on 10 health dimensions. Using the
new ﬁve dimensions, the area under the curve was 0.82 (P,
0.001). When all 10 problems were included in the model, the
area under the ROC curve improved to 0.86 (P, 0.001).
Ceiling effect
In the sample that completed the extended version of the ques-
tionnaire, 40.2% reported no problems in the original EQ-5D
dimensions (Table 5). In this subgroup (and excluding 3
respondents who had missing values on the additional health
dimensions), 59 respondents had at least one problem in one
of the added dimensions, leaving 75 with no problem in the 10
dimensions of the extended questionnaire. Comparisons of
other health-related variables conﬁrmed that the additional
health dimensions did identify sicker individuals among those
who reported no problems on the original EQ-5D.
Discussion
This study suggests that a utility measurement instrument
that is limited to ﬁve dimensions of health will miss
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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Table 4 Variance in perceived health status explained by the
original 5 EQ-5D dimensions, the new 5 dimensions and all
10 dimensions, overall and in population subgroups







Overall 0.47 (0.65) 0.47 (0.65) 0.56 (0.78)
Sex
Women 0.53 (0.74) 0.48 (0.67) 0.60 (0.83)
Men 0.40 (0.56) 0.49 (0.68) 0.53 (0.74)
Age (years)
20–59 0.48 (0.67) 0.44 (0.61) 0.54 (0.75)
60 0.45 (0.63) 0.45 (0.63) 0.54 (0.75)
Country of birth
Switzerland 0.44 (0.61) 0.42 (0.58) 0.54 (0.75)
Other 0.48 (0.67) 0.56 (0.78) 0.60 (0.83)
Highest schooling completed
Basica 0.52 (0.72) 0.53 (0.74) 0.60 (0.83)
Advancedb 0.33 (0.46) 0.29 (0.40) 0.41 (0.57)
Chronic health problem
No 0.31 (0.43) 0.29 (0.40) 0.41 (0.57)
Yes 0.38 (0.53) 0.48 (0.67) 0.52 (0.72)
aElementary or vocational.
bBaccalaureate, professional school or university.
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Table 3 Linear regression models relating absence of problems in health dimensions to VAS health rating (thermometer)
Full sample (n ¼ 1845
with complete data)
Subset who rated 10 dimensions (n ¼ 333 with complete
data)
Predictors in model Original 5 predictors 5 predictors (separate
models for EQ-5D and
new dimensions)
All 10 predictors
Absence of problema in: Difference P value Difference P value Difference P value
Mobility (EQ-5D) 9.7 ,0.001 10.3 ,0.001 7.1 0.002
Self-care (EQ-5D) 13.4 ,0.001 14.8 0.003 11.2 0.033
Usual activities (EQ-5D) 15.2 ,0.001 11.8 ,0.001 10.1 ,0.001
Pain/discomfort (EQ-5D) 8.1 ,0.001 8.8 ,0.001 4.9 ,0.001
Anxiety/depression (EQ-5D) 6.0 ,0.001 4.5 ,0.001 0.5 0.69
Sleep (new) 5.6 ,0.001 3.7 0.003
Memory/concentration (new) 4.7 0.001 3.3 0.009
Fatigue/energy (new) 8.5 ,0.001 5.2 ,0.001
Sight/hearing (new) 7.2 ,0.001 4.2 0.001
Contacts with others (new) 10.5 ,0.001 6.4 0.007
aCompared with moderate or severe problem.
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important health problems in a large proportion of members
of the general public. Furthermore, ﬁve alternative health
dimensions that were identiﬁed through literature review
were just as able to explain self-perceived health as the orig-
inal EQ-5D dimensions. Inclusion of all 10 items improved
the proportion of variance in self-perceived health that can
be explained by speciﬁc health issues.
The newly proposed items identiﬁed problems that were
common in this population. More than half of the respon-
dents reported feeling tired or lacking in energy, more than a
third reported problems with sleep and with memory or con-
centration and more than a quarter had problems seeing or
hearing. Only ‘contacts with others’ revealed problems in less
than 10% of the respondents. Omitting these dimensions
(with the possible exception of ‘contacts with others’) from
multi-attribute health-utility instruments entails a substantial
loss of information.
Furthermore, the proportion of variance explained in self-
perceived health (measured by the thermometer VAS) was
identical for the original EQ-5D items and the ﬁve new
items. It seems that the original dimensions of EQ-5D are
not particularly fundamental to explaining differences in
health. This observation calls in question the content validity
of currently available multi-attribute instruments, and the
methods by which health dimensions are selected for
inclusion. Further work may be needed to identify the
dimensions of health that cause most losses of health utility.
It may be that these dimensions will vary with the population
of interest—e.g. general population studies may require a
different set of dimensions than speciﬁc patient groups. For
instance, in our data, the EQ-5D dimensions explained a
larger part of variance in health among women than among
men, which was not the case for the new dimensions.
Once the most relevant health dimensions are identiﬁed
or ranked in order of importance, a difﬁcult decision is to
decide how many should be included. Practical consider-
ations dictate as few as possible, but measurement
requirements call for some criterion of comprehensiveness,
such as the proportion of variance in health explained by the
instrument. While there are no universal rules for interpret-
ing R2 statistics, we would consider that 0.47 of variance
explained (or 0.65 after correction for attenuation) is insufﬁ-
cient if the predictors (the health problems) are used as
proxies of the dependent variable (health utility), and if the
results of such analyses are to guide health policy decisions
or patient care. However, on this point opinions may differ.
Our results provide a realistic estimate of the improvement
that can be achieved by increasing the number of dimensions
of health-utility instruments. By adding ﬁve dimensions, the
proportion of variance explained went from 0.47 to 0.56 (or
from 0.65 to 0.78 after correcting for attenuation) and the area
under the ROC curve in predicting excellent or very good
health increased from 0.79 to 0.86. We would consider that a
substantial improvement, but whether it is sufﬁcient remains
debatable. Furthermore, we are aware of the practical difﬁcul-
ties. Increasing the number of dimensions entails a substantial
cost, by making the valuation procedures using preference-
based methods exponentially more complex. An alternative
possibility is that a smaller subset of health dimensions can be
identiﬁed that would explain a sufﬁciently large part of the var-
iance in health and health utility. Possibly, a different subset
would be needed for different subgroups of the population.
In choosing the relevant health dimensions, content val-
idity is an important concern. In this study, we did not deﬁne
health, but relied instead on the respondents’ lay deﬁnitions.
Clearly the developers of multi-attribute health-utility instru-
ments are entitled to their own deﬁnitions, and these differ
across instruments. For instance, HUI developers aimed to
measure only (potential) function, not actual performance
[4], arguing that the latter depends also on opportunities and
choices made by the individual. In contrast, authors of
EQ-5D and SF-6D were interested in actual performance in
daily life. Choosing the right conceptual framework for health
is a key decision in health-utility measurement, and yet this
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Table 5 Analysis of the ceiling effect of the EQ-5D
Respondents with highest utility on EQ-5D
All (n ¼ 137) Below EQ-10D
ceiling (n ¼ 59)a
At EQ-10D
ceiling (n ¼ 75)a
P value
Problem with sleep 16 (11.7)
Problem with memory/concentration 23 (16.8)
Problem with fatigue/energy 33 (24.3)
Problem with sight/hearing 16 (11.9)
Problem with contacts with others 2 (1.5)
Acute health problem 5 (3.8) 4 (7.0) 1 (1.4) 0.17
Chronic health problem 14 (10.4) 11 (19.3) 3 (4.1) 0.008
Doctor visit in past 6 months 66 (50.8) 35 (63.6) 30 (42.3) 0.014
Hospitalization in past 6 months 2 (1.5) 2 (3.6) 0 (0) 0.19
Self-reported health ‘excellent’ or ‘very good’ 95 (74.8) 33 (61.1) 62 (84.9) 0.002
Health VAS, mean (SD) 88.8 (8.6) 85.8 (8.9) 90.8 (7.8) 0.001
aFour missing values.
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issue has been subjected to little debate thus far. Consensus
in this area would facilitate the selection of the most relevant
health dimensions for measurement.
This study has several limitations. We have explored self-
perceived health, not the value attributed to one’s health. It
may be reasonable to assume that health problems that inﬂu-
ence the perception of health would also inﬂuence the will-
ingness to trade time for health improvement, but it does
not necessarily follow that the strength of the associations
would be similar. For example, people may be more willing
to trade life expectancy for relief from pain than for relief
from fatigue. Secondly, our study tested only ﬁve new dimen-
sions of health. While their choice seemed reasonable based
on the available literature, the list is by no means closed. In
fact, at the outset we hoped to identify one or two health
dimensions that would improve the performance of the exist-
ing instrument, and did not expect to discover that the selec-
tion of relevant dimensions was such an open question. In
view of our results, a more thorough exploration of health
dimensions that affect health utility, using a larger sample,
would be in order. Finally, the response rate of 50% raises
the risk of selection bias, such as the healthy volunteer effect.
However, we believe that selection bias is less likely to affect
associations between variables, the focus of our study.
This study suggests that self-perceived health among the
general public is inﬂuenced by more health dimensions than
are typically measured in a multi-attribute health-utility
instrument. Devising a brief but sufﬁciently comprehensive
instrument is a challenge for the science of health-utility
assessment.
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